Neuronetics (STIM) Liabilities and Shareholders Equity (2017 - 2026)

Neuronetics (STIM) has reported Liabilities and Shareholders Equity for 10 consecutive years, with $125.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 11.65% year-over-year to $125.4 million; the TTM figure through Mar 2026 stood at $547.1 million (up 20.56% YoY), while the FY2025 annual figure was $141.6 million, changed 0.46% from the prior year.
• Liabilities and Shareholders Equity eased to $125.4 million in Q1 2026 per STIM's latest filing, from $141.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $145.5 million in Q3 2025 and bottomed at $74.1 million in Q3 2024.
• Historically, Liabilities and Shareholders Equity has averaged $118.0 million across 5 years, with a median of $119.2 million in 2022.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity decreased 22.01% — and 2025, when it jumped 96.26%.
• Neuronetics' Liabilities and Shareholders Equity stood at $116.9 million in 2022, then slipped by 0.9% to $115.8 million in 2023, then climbed by 21.65% to $140.9 million in 2024, then gained by 0.46% to $141.6 million in 2025, then decreased by 11.38% to $125.4 million in 2026.
• Business Quant data shows STIM's Liabilities and Shareholders Equity at $125.4 million in Q1 2026, $141.6 million in Q4 2025, and $145.5 million in Q3 2025.